menu

CME: Update on Psoriasis and PsA: Best Practices in Dermatology

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Update on Psoriasis and PsA: Best Practices in Dermatology

Update on Psoriasis and PsA: Best Practices in Dermatology
RestartResume
This activity will address best practices in dermatology as well as specialty collaboration and comanagement in the treatment of psoriatic disease.

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Despite numerous advances in treatment for psoriasis and psoriatic arthritis (PsA), many patients continue to experience negative health consequences that could be prevented or improved with optimal evidence-based care. Dermatology, rheumatology, and primary care clinicians can improve outcomes for their patients by increasing their knowledge and competency in diagnosis, management, and interdisciplinary care coordination. This activity will address best practices in dermatology as well as specialty collaboration and comanagement in the treatment of psoriatic disease.

  • Disclosure of Conflicts of Interest

    Alexis Ogdie, MD, MSCE, discloses the following conflicts of interest. 
    Grant support: Novartis, Pfizer
    Consultant: AbbVie, BMS, Lilly, Pfizer, Novartis, Takeda 

    Joseph F. Merola, MD, MMSc, discloses the following conflicts of interest.
    Grant support: Biogen, Incyte, Novartis, Pfizer, Sanofi/Regeneron
    Consultant: AbbVie, Celgene, GSK, Janssen, Lilly, Merck, Novartis, Sanofi/Regeneron, UCB
    Speaker: AbbVie

    Bruce C. Gebhardt, MD, Professor, University of Cincinnati, CME Reviewer-Compliance has no conflicts of interest to disclose.
    Susan P. Tyler, MEd, CMP, CHCP, CME Director, University of Cincinnati, has no conflicts of interest to disclose.
    Jennifer Holzberger, Program Coordinator, University of Cincinnati, has no conflicts of interest to disclose.
    Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.
    Terry Ann Glauser, MD, MPH, Vice President, Medical Affairs, MCM Education, has no conflicts of interest to disclose.

    The University of Cincinnati requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications. 

    In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses. 

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Target Audience

    Dermatologists, rheumatologists, and primary care physicians (PCPs), as well as dermatology, rheumatology, and primary care nurse practitioners (NPs) and physician assistants (PAs) involved in the diagnosis and management of patients with psoriasis or PsA.

  • Learning Objectives

    Upon completion of this educational activity, participants should be able to:

    1. Assess patients with psoriasis for signs and symptoms of PsA.
    2. Discuss strategies for selecting psoriasis and PsA treatment that is tailored to specific disease and patient characteristics.
    3. Describe strategies to facilitate effective multidisciplinary care of patients with psoriasis and with PsA.
  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians. 

    The University of Cincinnati designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    This CME activity was developed through the joint providership of the University of Cincinnati and MCM Education.

    Release date: April 20, 2018 
    Last review date: April 20, 2018 
    Expiration date: April 20, 2019

    Accreditation Support: 
    Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277

    Technical Support: 
    For any technical issues or issues with your CME Certificate, please contact info@cmecorner.com

     

  • Provider(s)/Educational Partner(s)

         

  • Commercial Support

    This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.